Site içinde arama yapın

bir ses eklendi Health

2026-05-26 07:07:31 -

ERK1 Antibody Market: How Is Extracellular Signal-Regulated Kinase 1 Research Reagent Demand Driving the Academic and Biopharma Discovery Segment?

ERK1 (MAPK3) antibody research tools — the monoclonal and polyclonal antibody systems enabling Western blot, immunohistochemistry, flow cytometry, and immunoprecipitation detection of the 42 kDa ERK1 kinase representing the most fundamental reagent in MAPK/ERK pathway research — creates the most commercially dynamic market segment, with the ERK1 Antibody Market reflecting research...

0 Yorumlar 0 hisse senetleri 118 Views 0 önizleme